Cargando…
Genetic screening reveals a link between Wnt signaling and antitubulin drugs
The antitubulin drugs, paclitaxel (PX) and colchicine (COL), inhibit cell growth and are therapeutically valuable. PX stabilizes microtubules, while COL promotes their depolymerization. But, the drug concentrations that alter tubulin polymerization are hundreds of times higher than their clinically...
Autores principales: | Khan, A H, Bloom, J S, Faridmoayer, E, Smith, D J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705004/ https://www.ncbi.nlm.nih.gov/pubmed/26149735 http://dx.doi.org/10.1038/tpj.2015.50 |
Ejemplares similares
-
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling
por: Zhao, Yulei, et al.
Publicado: (2015) -
Combretastatin-Inspired Heterocycles as Antitubulin
Anticancer Agents
por: Hura, Neha, et al.
Publicado: (2018) -
A Screen for Kinetochore-Microtubule Interaction Inhibitors Identifies Novel Antitubulin Compounds
por: Screpanti, Emanuela, et al.
Publicado: (2010) -
Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line
Publicado: (1982) -
Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents
por: Duan, Yong-Tao, et al.
Publicado: (2016)